Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 384

1.

Toll-like Interleukin 1 Receptor Regulator Is an Important Modulator of Inflammation Responsive Genes.

Kashem MA, Li H, Toledo NP, Omange RW, Liang B, Liu LR, Li L, Yang X, Yuan XY, Kindrachuk J, Plummer FA, Luo M.

Front Immunol. 2019 Feb 28;10:272. doi: 10.3389/fimmu.2019.00272. eCollection 2019.

2.

Mucosal antibody responses to vaccines targeting SIV protease cleavage sites or full-length Gag and Env proteins in Mauritian cynomolgus macaques.

Li H, Hai Y, Lim SY, Toledo N, Crecente-Campo J, Schalk D, Li L, Omange RW, Dacoba TG, Liu LR, Kashem MA, Wan Y, Liang B, Li Q, Rakasz E, Schultz-Darken N, Alonso MJ, Plummer FA, Whitney JB, Luo M.

PLoS One. 2018 Aug 28;13(8):e0202997. doi: 10.1371/journal.pone.0202997. eCollection 2018.

3.

Hypothetical endogenous SIV-like antigens in Mauritian cynomolgus macaques.

Li H, Li L, Liu LR, Omange RW, Toledo N, Kashem MA, Hai Y, Liang B, Plummer FA, Luo M.

Bioinformation. 2018 Feb 28;14(2):48-52. doi: 10.6026/97320630014048. eCollection 2018.

4.

Identification and Characterization of Positively Selected Mutations in Nef of Four HIV-1 Major Subtypes from Los Alamos National Laboratory.

Shadabi E, Liang B, Plummer F, Luo M.

Curr HIV Res. 2018;16(2):130-142. doi: 10.2174/1570162X16666180330140807.

PMID:
29600767
5.

HIV-1 Subtypes and 5'LTR-Leader Sequence Variants Correlate with Seroconversion Status in Pumwani Sex Worker Cohort.

Sampathkumar R, Scott-Herridge J, Liang B, Kimani J, Plummer FA, Luo M.

Viruses. 2017 Dec 23;10(1). pii: E4. doi: 10.3390/v10010004.

6.

KIR3DL1 alleles and their epistatic interactions with human leukocyte antigen class I influence resistance and susceptibility to HIV-1 acquisition in the Pumwani sex worker cohort.

Luo M, Czarnecki C, Nebroski M, Kimani J, Bernard N, Plummer FA.

AIDS. 2018 Apr 24;32(7):841-850. doi: 10.1097/QAD.0000000000001735.

PMID:
29280757
7.

From bench to almost bedside: the long road to a licensed Ebola virus vaccine.

Wong G, Mendoza EJ, Plummer FA, Gao GF, Kobinger GP, Qiu X.

Expert Opin Biol Ther. 2018 Feb;18(2):159-173. doi: 10.1080/14712598.2018.1404572. Epub 2017 Nov 17. Review.

8.

The story of Canada's Ebola vaccine.

Plummer FA, Jones SM.

CMAJ. 2017 Oct 30;189(43):E1326-E1327. doi: 10.1503/cmaj.170704. No abstract available.

9.

Natural and cross-inducible anti-SIV antibodies in Mauritian cynomolgus macaques.

Li H, Nykoluk M, Li L, Liu LR, Omange RW, Soule G, Schroeder LT, Toledo N, Kashem MA, Correia-Pinto JF, Liang B, Schultz-Darken N, Alonso MJ, Whitney JB, Plummer FA, Luo M.

PLoS One. 2017 Oct 5;12(10):e0186079. doi: 10.1371/journal.pone.0186079. eCollection 2017.

10.

A novel HIV vaccine targeting the protease cleavage sites.

Li H, Omange RW, Plummer FA, Luo M.

AIDS Res Ther. 2017 Sep 12;14(1):51. doi: 10.1186/s12981-017-0174-7. Review.

11.

Cost and Outcome of BehaviouRal Activation (COBRA): a randomised controlled trial of behavioural activation versus cognitive-behavioural therapy for depression.

Richards DA, Rhodes S, Ekers D, McMillan D, Taylor RS, Byford S, Barrett B, Finning K, Ganguli P, Warren F, Farrand P, Gilbody S, Kuyken W, O'Mahen H, Watkins E, Wright K, Reed N, Fletcher E, Hollon SD, Moore L, Backhouse A, Farrow C, Garry J, Kemp D, Plummer F, Warner F, Woodhouse R.

Health Technol Assess. 2017 Aug;21(46):1-366. doi: 10.3310/hta21460.

12.

Clinical Evaluation of Ebola Virus Disease Therapeutics.

Liu G, Wong G, Su S, Bi Y, Plummer F, Gao GF, Kobinger G, Qiu X.

Trends Mol Med. 2017 Sep;23(9):820-830. doi: 10.1016/j.molmed.2017.07.002. Epub 2017 Aug 17. Review.

13.

Mauritian cynomolgus macaques with M3M4 MHC genotype control SIVmac251 infection.

Li H, Omange RW, Czarnecki C, Correia-Pinto JF, Crecente-Campo J, Richmond M, Li L, Schultz-Darken N, Alonso MJ, Whitney JB, Plummer FA, Luo M.

J Med Primatol. 2017 Aug;46(4):137-143. doi: 10.1111/jmp.12300.

14.

Clinical effectiveness, cost-effectiveness and acceptability of low-intensity interventions in the management of obsessive-compulsive disorder: the Obsessive-Compulsive Treatment Efficacy randomised controlled Trial (OCTET).

Lovell K, Bower P, Gellatly J, Byford S, Bee P, McMillan D, Arundel C, Gilbody S, Gega L, Hardy G, Reynolds S, Barkham M, Mottram P, Lidbetter N, Pedley R, Molle J, Peckham E, Knopp-Hoffer J, Price O, Connell J, Heslin M, Foley C, Plummer F, Roberts C.

Health Technol Assess. 2017 Jun;21(37):1-132. doi: 10.3310/hta21370.

15.

Low-intensity cognitive-behaviour therapy interventions for obsessive-compulsive disorder compared to waiting list for therapist-led cognitive-behaviour therapy: 3-arm randomised controlled trial of clinical effectiveness.

Lovell K, Bower P, Gellatly J, Byford S, Bee P, McMillan D, Arundel C, Gilbody S, Gega L, Hardy G, Reynolds S, Barkham M, Mottram P, Lidbetter N, Pedley R, Molle J, Peckham E, Knopp-Hoffer J, Price O, Connell J, Heslin M, Foley C, Plummer F, Roberts C.

PLoS Med. 2017 Jun 27;14(6):e1002337. doi: 10.1371/journal.pmed.1002337. eCollection 2017 Jun.

16.

Identifying depression with the PHQ-2: A diagnostic meta-analysis.

Manea L, Gilbody S, Hewitt C, North A, Plummer F, Richardson R, Thombs BD, Williams B, McMillan D.

J Affect Disord. 2016 Oct;203:382-395. doi: 10.1016/j.jad.2016.06.003. Epub 2016 Jun 6.

PMID:
27371907
17.

Screening for anxiety disorders with the GAD-7 and GAD-2: a systematic review and diagnostic metaanalysis.

Plummer F, Manea L, Trepel D, McMillan D.

Gen Hosp Psychiatry. 2016 Mar-Apr;39:24-31. doi: 10.1016/j.genhosppsych.2015.11.005. Epub 2015 Nov 18. Review.

PMID:
26719105
18.

Reducing IRF-1 to Levels Observed in HESN Subjects Limits HIV Replication, But Not the Extent of Host Immune Activation.

Su RC, Plesniarski A, Ao Z, Kimani J, Sivro A, Jaoko W, Plummer FA, Yao X, Ball TB.

Mol Ther Nucleic Acids. 2015 Oct 27;4:e259. doi: 10.1038/mtna.2015.29.

19.

Correction: Non-Cationic Proteins Are Associated with HIV Neutralizing Activity in Genital Secretions of Female Sex Workers.

Birse KD, Cole AL, Hirbod T, McKinnon L, Ball TB, Westmacott GR, Kimani J, Plummer F, Cole AM, Burgener A, Broliden K.

PLoS One. 2015 Jul 21;10(7):e0134196. doi: 10.1371/journal.pone.0134196. eCollection 2015. No abstract available.

20.

Non-Cationic Proteins Are Associated with HIV Neutralizing Activity in Genital Secretions of Female Sex Workers.

Birse KD, Cole AL, Hirbod T, McKinnon L, Ball TB, Westmacott GR, Kimani J, Plummer F, Cole AM, Burgener A, Broliden K.

PLoS One. 2015 Jun 19;10(6):e0130404. doi: 10.1371/journal.pone.0130404. eCollection 2015. Erratum in: PLoS One. 2015;10(7):e0134196.

21.

HIV-infected sex workers with beneficial HLA-variants are potential hubs for selection of HIV-1 recombinants that may affect disease progression.

Chang CH, Kist NC, Stuart Chester TL, Sreenu VB, Herman M, Luo M, Lunn D, Bell J, Plummer FA, Ball TB, Katzourakis A, Iversen AK.

Sci Rep. 2015 Jun 17;5:11253. doi: 10.1038/srep11253.

22.

HLA Class II Antigens and Their Interactive Effect on Perinatal Mother-To-Child HIV-1 Transmission.

Luo M, Embree J, Ramdahin S, Bielawny T, Laycock T, Tuff J, Haber D, Plummer M, Plummer FA.

PLoS One. 2015 May 6;10(5):e0126068. doi: 10.1371/journal.pone.0126068. eCollection 2015.

23.

Elevated expression of LAG-3, but not PD-1, is associated with impaired iNKT cytokine production during chronic HIV-1 infection and treatment.

Juno JA, Stalker AT, Waruk JL, Oyugi J, Kimani M, Plummer FA, Kimani J, Fowke KR.

Retrovirology. 2015 Feb 13;12:17. doi: 10.1186/s12977-015-0142-z.

24.

Mx2 expression is associated with reduced susceptibility to HIV infection in highly exposed HIV seronegative Kenyan sex workers.

Stein DR, Shaw SY, McKinnon LR, Abou M, McCorrister SJ, Westmacott GR, Fowke KR, Plummer FA, Ball TB.

AIDS. 2015 Jan 2;29(1):35-41. doi: 10.1097/QAD.0000000000000490.

PMID:
25562491
25.

Enrichment of LAG-3, but not PD-1, on double negative T cells at the female genital tract.

Juno JA, Lajoie J, Stalker AT, Oyugi J, Kimani M, Kimani J, Plummer FA, Fowke KR.

Am J Reprod Immunol. 2014 Dec;72(6):534-40. doi: 10.1111/aji.12308. Epub 2014 Aug 25.

PMID:
25154740
26.

Experimental countermeasures against Ebola virus: current progress and an ethical conundrum.

Plummer FA, Wong G, Kobinger GP.

CMAJ. 2014 Oct 21;186(15):1129-30. doi: 10.1503/cmaj.141061. Epub 2014 Aug 19. No abstract available.

27.

Influence of HLA class I haplotypes on HIV-1 seroconversion and disease progression in Pumwani sex worker cohort.

Sampathkumar R, Peters HO, Mendoza L, Bielawny T, Ngugi E, Kimani J, Wachihi C, Plummer FA, Luo M.

PLoS One. 2014 Jul 3;9(7):e101475. doi: 10.1371/journal.pone.0101475. eCollection 2014.

28.

Development of monoclonal antibodies to interrogate functional domains and isoforms of FREM1 protein.

Yuan XY, Liu LR, Krawchenko A, Sainsbury J, Zhao L, Plummer F, Yang X, Luo M.

Monoclon Antib Immunodiagn Immunother. 2014 Apr;33(2):129-40. doi: 10.1089/mab.2013.0058.

PMID:
24746155
29.

Predicting HLA alleles from high-resolution SNP data in three Southeast Asian populations.

Pillai NE, Okada Y, Saw WY, Ong RT, Wang X, Tantoso E, Xu W, Peterson TA, Bielawny T, Ali M, Tay KY, Poh WT, Tan LW, Koo SH, Lim WY, Soong R, Wenk M, Raychaudhuri S, Little P, Plummer FA, Lee EJ, Chia KS, Luo M, De Bakker PI, Teo YY.

Hum Mol Genet. 2014 Aug 15;23(16):4443-51. doi: 10.1093/hmg/ddu149. Epub 2014 Apr 3.

PMID:
24698974
30.

Presence of CD8+ T cells in the ectocervical mucosa correlates with genital viral shedding in HIV-infected women despite a low prevalence of HIV RNA-expressing cells in the tissue.

Gibbs A, Hirbod T, Li Q, Bohman K, Ball TB, Plummer FA, Kaul R, Kimani J, Broliden K, Tjernlund A.

J Immunol. 2014 Apr 15;192(8):3947-57. doi: 10.4049/jimmunol.1302826. Epub 2014 Mar 17.

31.

Interferon responses in HIV infection: from protection to disease.

Sivro A, Su RC, Plummer FA, Ball TB.

AIDS Rev. 2014 Jan-Mar;16(1):43-51.

PMID:
24522779
32.

Age and menopause affect the expression of specific cytokines/chemokines in plasma and cervical lavage samples from female sex workers in Nairobi, Kenya.

Sivro A, Lajoie J, Kimani J, Jaoko W, Plummer FA, Fowke K, Ball TB.

Immun Ageing. 2013 Oct 22;10(1):42. doi: 10.1186/1742-4933-10-42.

33.

Association of sex work with reduced activation of the mucosal immune system.

Lajoie J, Kimani M, Plummer FA, Nyamiobo F, Kaul R, Kimani J, Fowke KR.

J Infect Dis. 2014 Jul 15;210(2):319-29. doi: 10.1093/infdis/jiu023. Epub 2014 Jan 12.

PMID:
24421257
34.

Stable CD4 expression and local immune activation in the ectocervical mucosa of HIV-infected women.

Hirbod T, Kimani J, Tjernlund A, Cheruiyot J, Petrova A, Ball TB, Mugo N, Jaoko W, Plummer FA, Kaul R, Broliden K.

J Immunol. 2013 Oct 1;191(7):3948-54. doi: 10.4049/jimmunol.1301220. Epub 2013 Sep 4.

35.

HIV and interferon regulatory factor 1: a story of manipulation and control.

Sivro A, Su RC, Plummer FA, Ball TB.

AIDS Res Hum Retroviruses. 2013 Nov;29(11):1428-33. doi: 10.1089/AID.2013.0098. Epub 2013 Sep 25. Review.

PMID:
23984938
36.

High pH reversed-phase chromatography as a superior fractionation scheme compared to off-gel isoelectric focusing for complex proteome analysis.

Stein DR, Hu X, McCorrister SJ, Westmacott GR, Plummer FA, Ball TB, Carpenter MS.

Proteomics. 2013 Oct;13(20):2956-66. doi: 10.1002/pmic.201300079.

PMID:
23956148
37.

Association study of common genetic variants and HIV-1 acquisition in 6,300 infected cases and 7,200 controls.

McLaren PJ, Coulonges C, Ripke S, van den Berg L, Buchbinder S, Carrington M, Cossarizza A, Dalmau J, Deeks SG, Delaneau O, De Luca A, Goedert JJ, Haas D, Herbeck JT, Kathiresan S, Kirk GD, Lambotte O, Luo M, Mallal S, van Manen D, Martinez-Picado J, Meyer L, Miro JM, Mullins JI, Obel N, O'Brien SJ, Pereyra F, Plummer FA, Poli G, Qi Y, Rucart P, Sandhu MS, Shea PR, Schuitemaker H, Theodorou I, Vannberg F, Veldink J, Walker BD, Weintrob A, Winkler CA, Wolinsky S, Telenti A, Goldstein DB, de Bakker PI, Zagury JF, Fellay J.

PLoS Pathog. 2013;9(7):e1003515. doi: 10.1371/journal.ppat.1003515. Epub 2013 Jul 25.

38.

Identification of three novel human leukocyte antigen alleles, HLA-B*58:43, HLA-C*03:190, and HLA-DPA1*01:12, in an East African cohort.

Nykoluk M, Bailey RC, Moses S, Plummer FA, Luo M.

Tissue Antigens. 2013 Aug;82(2):131-3. doi: 10.1111/tan.12157.

PMID:
23849069
39.

Acting locally: innate mucosal immunity in resistance to HIV-1 infection in Kenyan commercial sex workers.

Yao XD, Omange RW, Henrick BM, Lester RT, Kimani J, Ball TB, Plummer FA, Rosenthal KL.

Mucosal Immunol. 2014 Mar;7(2):268-79. doi: 10.1038/mi.2013.44. Epub 2013 Jun 26.

PMID:
23801306
40.

Interferon regulatory factor 1 polymorphisms previously associated with reduced HIV susceptibility have no effect on HIV disease progression.

Sivro A, McKinnon LR, Ji H, Kimani J, Jaoko W, Plummer FA, Su RC, Ball TB.

PLoS One. 2013 Jun 14;8(6):e66253. doi: 10.1371/journal.pone.0066253. Print 2013.

41.

A naturally occurring Vif mutant (I107T) attenuates anti-APOBEC3G activity and HIV-1 replication.

Peng J, Ao Z, Matthews C, Wang X, Ramdahin S, Chen X, Li J, Chen L, He J, Ball B, Fowke K, Plummer F, Embree J, Yao X.

J Mol Biol. 2013 Aug 23;425(16):2840-52. doi: 10.1016/j.jmb.2013.05.015. Epub 2013 May 23.

PMID:
23707381
42.

Immunogenicity of sequences around HIV-1 protease cleavage sites: potential targets and population coverage analysis for a HIV vaccine targeting protease cleavage sites.

Luo M, Capina R, Daniuk C, Tuff J, Peters H, Kimani M, Wachihi C, Kimani J, Ball TB, Plummer FA.

Vaccine. 2013 Jun 24;31(29):3000-8. doi: 10.1016/j.vaccine.2013.04.057. Epub 2013 May 10.

PMID:
23664989
43.

HLA class I associations with rates of HIV-1 seroconversion and disease progression in the Pumwani Sex Worker Cohort.

Peterson TA, Kimani J, Wachihi C, Bielawny T, Mendoza L, Thavaneswaran S, Narayansingh MJ, Kariri T, Liang B, Ball TB, Ngugi EN, Plummer FA, Luo M.

Tissue Antigens. 2013 Feb;81(2):93-107. doi: 10.1111/tan.12051.

PMID:
23330720
44.

Anti-HIV-1 activity of elafin depends on its nuclear localization and altered innate immune activation in female genital epithelial cells.

Drannik AG, Nag K, Yao XD, Henrick BM, Ball TB, Plummer FA, Wachihi C, Kimani J, Rosenthal KL.

PLoS One. 2012;7(12):e52738. doi: 10.1371/journal.pone.0052738. Epub 2012 Dec 27.

45.

HLA-G and mother-child perinatal HIV transmission.

Luo M, Czarnecki C, Ramdahin S, Embree J, Plummer FA.

Hum Immunol. 2013 Apr;74(4):459-63. doi: 10.1016/j.humimm.2012.11.023. Epub 2012 Dec 10.

PMID:
23238215
46.

Quality of interaction between at-risk infants and caregiver at 12-15 months is associated with 3-year autism outcome.

Wan MW, Green J, Elsabbagh M, Johnson M, Charman T, Plummer F; BASIS Team.

J Child Psychol Psychiatry. 2013 Jul;54(7):763-71. doi: 10.1111/jcpp.12032. Epub 2012 Dec 11.

PMID:
23227853
47.

HIV-1 clade D is associated with increased rates of CD4 decline in a Kenyan cohort.

McKinnon LR, Nagelkerke NJ, Kaul R, Shaw SY, Capina R, Luo M, Kariri A, Apidi W, Kimani M, Wachihi C, Jaoko W, Anzala AO, Kimani J, Ball TB, Plummer FA.

PLoS One. 2012;7(11):e49797. doi: 10.1371/journal.pone.0049797. Epub 2012 Nov 21.

48.

Associations of human leukocyte antigen-G with resistance and susceptibility to HIV-1 infection in the Pumwani sex worker cohort.

Turk WJ, Kimani J, Bielawny T, Wachihi C, Ball TB, Plummer FA, Luo M.

AIDS. 2013 Jan 2;27(1):7-15. doi: 10.1097/QAD.0b013e32835ab1f2.

PMID:
23032415
49.

Reduced cellular susceptibility to in vitro HIV infection is associated with CD4+ T cell quiescence.

Card CM, Rutherford WJ, Ramdahin S, Yao X, Kimani M, Wachihi C, Kimani J, Plummer FA, Ball TB, Fowke KR.

PLoS One. 2012;7(9):e45911. doi: 10.1371/journal.pone.0045911. Epub 2012 Sep 21.

50.

Mucosal serpin A1 and A3 levels in HIV highly exposed sero-negative women are affected by the menstrual cycle and hormonal contraceptives but are independent of epidemiological confounders.

Rahman S, Rabbani R, Wachihi C, Kimani J, Plummer FA, Ball TB, Burgener A.

Am J Reprod Immunol. 2013 Jan;69(1):64-72. doi: 10.1111/aji.12014. Epub 2012 Sep 13.

PMID:
22971020

Supplemental Content

Loading ...
Support Center